Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice.
Wanniarachchi HI, Schuetze R, Deng Y, Hamal KB, Pavlich CI, Tankoano PEO, Tamminga C, Hammers H, Kapur P, Bueno LMA, Rayas R, Wang T, Liu L, Trawick ML, Pinney KG, Mason RP.
Wanniarachchi HI, et al.
Cancers (Basel). 2025 Feb 24;17(5):771. doi: 10.3390/cancers17050771.
Cancers (Basel). 2025.
PMID: 40075618
Free PMC article.